You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Biological effect of microengineered grooved stents on strut healing: a randomised OCT-based comparative study in humans

Responses

Article menu

This article has a correction. Please see:

Download PDFPDF

Interventional cardiology
Original research article
Biological effect of microengineered grooved stents on strut healing: a randomised OCT-based comparative study in humans
Compose a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on: 21 December 2018
    Unanswered Questions

    In his response to my CardioBrief blog post (http://www.cardiobrief.org/2017/09/11/julio-palmaz-really-doesnt-want-yo...) Juan Granada implies that my article was neither factual, nor accurate, nor professional. However, at no point does Granada give examples backing his assertions.

    Granada neglects to mention that prior to publication of my blog post I had emailed him, offering him the opportunity to clarify or respond to the questions I raised prior to publication and to prevent any misunderstanding. Granada did not respond to my emails. In fact, after I emailed my questions to Granada I received a “cease-and-desist” letter from Julio Palmaz's attorneys. Is this his idea of "very high ethical and academic standards”?

    In his statement Granada also fails to address the differences between the listing of the study on ClinicalTrials.Org (https://clinicaltrials.gov/ct2/show/record/NCT02759406), in which the stents are described as Palmaz stents, and the Open Heart publication, in which they are described as Abbott stents. This discrepancy may, potentially, raise troubling issues, including questions about the IRB evaluation of the study and how the study was described to potential subjects during the informed consent process. Granada also offers no explanation for the discrepanc...

    Show More
    Conflict of Interest:
    None declared.
  • Published on: 4 July 2018
    Response to CardioBrief blog post
    • Juan F Granada, Cardiologist, President and CEO Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation, Orangeburg, New York, USA

    Clinical practice has been historically driven by evidence-based medicine. Properly sized randomized controlled trials have been the basis of accepting or rejecting research hypotheses, and clinical guidelines are developed based on data reported in such trials. Clinical research is not perfect. However, most clinical trials are conducted in a highly regulated environment and accepted for publication following a strict peer review process led by independent experts. While limitations exist in conducting and reporting clinical trials, investigators are judged at very high ethical and academic standards.

    A blog posted on September 11, 2017[1] questioned the integrity of the data and ethical conduct of the investigators of this study published in Open Heart. Due to the respect I have for the editor and this journal, I am obliged to respond on behalf of the authors.

    First, I did not receive ANY type of financial compensation as the principal investigator for this study. Second, no financial obligations or equity arrangements exist between the sponsor of the study, myself or my current Institution. Third, although all financial disclosures of all authors were properly disclosed to the journal at the time of submission, they were unfortunately not included in the final published article and therefore published subsequently as a correction[2]. Fourth, the objective of the study was to assess the 3-week healing properties of a surface-modified stent. The patient wi...

    Show More
    Conflict of Interest:
    None declared.